Addition of the PCSK9 inhibitor evolocumab to statin therapy after CABG surgery does not improve 24-month graft patency, in the NEWTON-CABG CardioLink-5 trial.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/ldl-lowering-not-answer-cabg-graft-failure-2025a1000ok4?src=rss
Author :
Publish date : 2025-09-17 07:31:00
Copyright for syndicated content belongs to the linked Source.
